Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Long-Term Investments: 2019-2021

  • Genmab A's Long-Term Investments was N/A to $997.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $997.2 million, marking a year-over-year change of. This contributed to the annual value of $188.4 million for FY2020, which is 75.58% down from last year.
  • Per Genmab A's latest filing, its Long-Term Investments stood at $997.2 million for Q2 2021, which was down 2.66% from $1.0 billion recorded in Q4 2020.
  • In the past 5 years, Genmab A's Long-Term Investments registered a high of $1.0 billion during Q4 2020, and its lowest value of $67.9 million during Q4 2019.
  • Its 3-year average for Long-Term Investments is $696.5 million, with a median of $997.2 million in 2021.
  • Data for Genmab A's Long-Term Investments shows a peak YoY soared of 1,408.64% (in 2020) over the last 5 years.
  • Genmab A's Long-Term Investments (Quarterly) stood at $67.9 million in 2019, then spiked by 1,408.64% to $1.0 billion in 2020, then reached $997.2 million in 2021.
  • Its Long-Term Investments stands at $997.2 million for Q2 2021, versus $1.0 billion for Q4 2020 and $67.9 million for Q4 2019.